Your browser doesn't support javascript.
loading
Rational design of coumarin derivatives as antituberculosis agents.
Mali, Hemlata M; Sabale, Sandip S; Degani, Mariam S; Borkute, Rachana; Choudhari, Amit S; Sarkar, Dhiman; Krishna, Vagolu Siva; Sriram, Dharmarajan.
Afiliación
  • Mali HM; Department of Pharmaceutical Sciences & Technology, Institute of Chemical Technology, Matunga (E), Mumbai 400019, India.
  • Sabale SS; Department of Pharmaceutical Sciences & Technology, Institute of Chemical Technology, Matunga (E), Mumbai 400019, India.
  • Degani MS; Department of Pharmaceutical Sciences & Technology, Institute of Chemical Technology, Matunga (E), Mumbai 400019, India.
  • Borkute R; CombiChem Bio Resource Centre, National Chemical Laboratory, Pune 411 008, India.
  • Choudhari AS; CombiChem Bio Resource Centre, National Chemical Laboratory, Pune 411 008, India.
  • Sarkar D; CombiChem Bio Resource Centre, National Chemical Laboratory, Pune 411 008, India.
  • Krishna VS; Department of Pharmacy, Birla Institute of Technology & Science-Pilani, Hyderabad Campus, Hyderabad 500078, India.
  • Sriram D; Department of Pharmacy, Birla Institute of Technology & Science-Pilani, Hyderabad Campus, Hyderabad 500078, India.
Future Med Chem ; 10(20): 2431-2444, 2018 10.
Article en En | MEDLINE | ID: mdl-30325198
ABSTRACT

AIM:

A series of coumarin derivatives was designed as potential antituberculosis agents.

RESULTS:

The compounds were screened against active and dormant Mycobacterium tuberculosis (Mtb). Compounds 3k and 3n were found to have the most promising activity against replicating MtbH37Rv exhibiting minimum inhibitory concentration of 4.63 and 9.75 µM respectively. The compounds were also effective against dormant MtbH37Rv exhibiting more potency than the standard drugs, isoniazid and rifampicin. The compounds were found to be non-cytotoxic against human cell lines.

CONCLUSION:

This study provides promising antituberculosis agents that are effective against replicating as well as dormant Mtb and can thus act as potential leads for further development.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cumarinas / Mycobacterium tuberculosis / Antituberculosos Límite: Humans Idioma: En Revista: Future Med Chem Año: 2018 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cumarinas / Mycobacterium tuberculosis / Antituberculosos Límite: Humans Idioma: En Revista: Future Med Chem Año: 2018 Tipo del documento: Article País de afiliación: India